TAKFA FORTE 1% OINT

About

Tacrolimus is a calcineurin inhibitor used topically to treat moderate to severe atopic dermatitis (eczema) in adults and children who are not adequately responsive to or are intolerant of conventional therapies. It works by inhibiting T-lymphocyte activation, thereby reducing the inflammatory response in the skin. Unlike corticosteroids, tacrolimus does not cause skin atrophy, making it suitable for long-term use and application on sensitive areas like the face and skin folds.

Its mechanism involves binding to an intracellular protein, FKBP-12, and the resulting complex inhibits calcineurin, preventing the dephosphorylation and nuclear translocation of NF-AT, a transcription factor crucial for cytokine gene expression. This targeted action helps to manage chronic inflammatory skin conditions effectively while minimizing steroid-related side effects.

Uses

• Treatment of moderate to severe atopic dermatitis.
• Management of eczema unresponsive to corticosteroids.
• Prevention of skin atrophy from prolonged steroid use.
• For use in sensitive skin areas like the face and neck.

Directions For Use

Apply a thin layer to affected skin areas twice daily. Rub in gently and completely.

Benefits

• Non-steroidal treatment for eczema.
• Reduces inflammation and itching effectively.
• Suitable for long-term use.
• Can be used on sensitive skin areas.
• Does not cause skin thinning (atrophy).
• Improves skin barrier function over time.

Side Effects

• Skin burning sensation
• Itching (pruritus)
• Erythema (redness)
• Skin irritation
• Folliculitis
• Acne
• Herpes simplex infection
• Alcohol intolerance (facial flushing)
• Headache
• Paresthesia
• Increased skin sensitivity to sun
• Allergic reactions

Safety Measures

• Alcohol - May cause facial flushing or skin irritation at the application site when alcohol is consumed.
• Pregnancy - Use with caution; consult a doctor. Systemic absorption is minimal but potential risks are not fully established.
• Breastfeeding - Unknown if tacrolimus is excreted in human milk after topical application. Use with caution and medical advice.
• Liver - Minimal systemic absorption, so generally safe for liver conditions, but caution is advised with extensive use on compromised skin.
• Kidney - Minimal systemic absorption, generally safe for kidney conditions, but caution is advised with extensive use on compromised skin.
• Lung - No specific contraindications related to lung conditions for topical tacrolimus.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.